From initial public offerings to mergers and acquisitions, pharmaceutical companies across the U.S. have been busy bringing on in-house legal chiefs since the start of the Covid-19 outbreak two months ago.
Atara Biotherapeutics Inc. May 6 confirmed its hire of senior vice president and general counsel K. Amar Murugan. He joined the immunotherapy company after more than seven years at Assertio Therapeutics Inc., a Newark, Calif.-based specialty pharmaceutical outfit formerly known as Depomed. Murugan spent the past two years as Assertio’s general counsel.
In March, Assertio merged with Wayne, Pa.-based Zyla Life Sciences in a $17.5 million all-stock deal forming ...